Biologics by McKesson continues to solidify its leadership position a provider for limited and exclusive drugs in the specialty pharmacy market
PYRUKYND prescriptions are processed exclusively through Biologics by McKesson to give patients a seamless experience
Amber Specialty Pharmacy announced that it will begin dispensing LIVTENCITY™ (maribavir), the first and only treatment indicated for the treatment of adults and pediatric patients (12 years of age and older and weighing at least 35 kg) with post-transplant CMV infection/disease
The FDA has accepted for Priority Review the supplemental New Drug Application (sNDA) for voxelotor (Oxbryta®) for the treatment of sickle cell disease in patients aged 4 to 11 years
Biologics specialty pharmacy teams includes pharmacists with in-depth knowledge of therapies, experienced nurses, and financial counselors who are familiar with various financial assistance programs and organizations that help patients